Mumbai: On the one hand, US President Donald Trump is becoming unpredictable by the news of Israeli’s preparation to attack Iran on Gaza and on the other hand, between Ukraine and Russia, which is becoming unpredictable, causing new tensions every day for the corporate world, all the countries are going into the pit of uncertainty and the global markets are in a ruckus. After adopting an aggressive stance to transfer manufacturing from technology giant Apple Ink to the US, Trump has once again provoked the calm war, threatening to put a 50 percent tariff on Samsung as well as the European Union. Trump’s tariff insanity is making global trade unstable, after the rise in global markets, Indian stock markets are also seen uncertain turmoil. The next week can be closed at 83111 at support level of Sensex 81444 and closure at 25444 when the Nifty Spot is closed at 25222.
In Arjun’s eyes: Sharda Cropkem Limited.
BSE (538666), NSE listed, payment of Rs 10, 75% promoter holding, Indian multinational company, ISO 9005: 2015 certified, Sharda Cropcime Limited is a rapidly growing global agricultural chemical company in the generic crop conservation chemistry industry. The company has created a deep presence in developed European and American markets, where entry barriers are considered very high. The company operates in Latin America and more than 80 countries in the rest of the world, including other regulated markets. The sales network of this company with more than 500 global employees is spread over Europe, America, Canada, Mexico, Colombia, South Africa and India. While the rest of the world has third party distributors.
As of 31 March 2025, the company has a total of 2964 product registrations. Additionally, 1014 global products are in the application registration process. The company’s business model is asset.
Sharda Bioside Europe: This business unit of Sharda Crop-Came Limited develops, manufactures and sells bioside products for public health and insect control. Sharda Bioside is an independent company. Some of the major points exposed by the company management on 15 May 2025: Despite global challenges and constant price pressures in the fourth quarter of the financial year 2025, the company has achieved a total revenue of 39 percent. 1829 crore Got more than 50 percent increase in quantity on an annual basis. Europe, Latin America and NAFTA have been important distributors in the agricultural chemical sector. The agricultural chemical segment has gained a 48 percent increase in sales. While the non-agricultural chemical segment has gained 116 percent year after year. The total margin received 29.8 percent. In FY 2026, further improvement in performance with stability in the prices of raw materials is expected to improve. EBITDA increased by 16 percent to Rs. 352 crores and net profit increased by 42 percent to Rs. 204 crores The total revenue increased by 37 percent to Rs. 4320 crores and volume growth was 42 percent.
Working Capital Day was 118 days till 31 March 2025. This indicates a 40 -day improvement compared to March 2024. The company has cash and cash equivalent worth Rs 5,000 crore. The company’s capital expenditure is Rs 558 crore by 31 March 2025. The cost of Rs 420 crore will come and the company is confident that with the ongoing product registration, capital expenditure is estimated to be within Rs 420 crore. 400 crores 450 crores in the year 2026.
Sharedrity Pattern: Promoter Bubna family holds 75%, Mutual Fund has 10%, FII has 4.69%, HNI and others have 3.54%and retail investors have 6.77%stake.
Dividend: 30 percent in 2021, 60 percent in 2022, 60 percent in 2023, 30 percent in 2024, 90 percent in 2025.
Income-EPS per share: Rs. 3136 in FY 2022. 35.99 in FY 2023. 15.16 in FY 2024. Rs 33.74 expected in FY 2025. 43 in FY 2026
Revenue: Rs. 2946 crore in FY 2022. 3312 crore in FY 2023. 2602 crore in FY 2024. 4320 crore is expected in FY 2025. 5100 crore rupees in FY 2026.
Book Value: Rs 192 till March 2022, Rs 222 till March 2023, Rs 234 till March 2024, Rs 268 by March 2025, Rs 311 till March 2026
Gold prices fast, silver also shines
financial result:
(1) Fourth quarter January 2025 to March 2025: Pure income increased by 39% to Rs. 1829 crore, net profit margin-NPM 11.15%, and net profit increased by 42% to Rs. A quarterly income of Rs 204 crore was earned per share-EPS. 22.57.
(2) Full year April 2024 to March 2025: Pure income increased by 37% to Rs. 4320 crores, net profit margin-NPM 7.03%, and net profit increased by 850% to Rs. Gained income-EPS of Rs 304 crore per share. 33.74.
(3) Expected full year April 2025 to March 2026: Expected net income increased by 18% to Rs. It is expected to be 1,00,000. 5100 crores, net profit margin 7.60% and net profit. 388 crore per share with income. 43.
Thus (1) The author has no investment in the shares of the above company. The author may have a direct or indirect personal interest in his research sources. Before taking any investment decision, consult a qualified investment financial advisor. The author, Gujarat News or any other person will not be responsible for any possible loss on investment.
